In a UK survey of the occurrence of extended spectrum -lactamases, 96 hospitals submitted a total of 3951 non-selected, non-duplicate isolates of Enterobacteriaceae from 100 patients in each hospital, 206 of these cultures being mixed and, therefore, discarded. These isolates were initially screened for strains likely to produce extended-spectrum -lactamases (ESBLs) by MIC determination of -lactams followed by a bioassay, then disc approximation test and isoelectric focusing (IEF). Isolates were further examined using two pairs of PCR primers for both bla TEM and bla SHV genes. The ability of isolates to transfer resistance to both cefotaxime and ceftazidime by conjugation and transformation were examined. Four hundred and nine cefotaxime/ceftazidime-resistant isolates (10.9%) were identified from the 3745 submitted isolates, of which 338 (9.0%) were Enterobacteriaceae, 29 Escherichia coli, 35 Klebsiella spp. and seven Hafnia alveii. IEF suggested that 17 isolates produced an ESBL, which was confirmed in most cases by PCR and hydrolysis, five isolates produced an SHV enzyme by IEF, but not confirmed by PCR, and 11 had isoelectric points in the range 8-9 suggesting a possible AmpC enzyme. Only two isolates transferred the determinants. In the case of the Klebsiella spp., 19 of the 24 ceftazidime-resistant/clavulanate-sensitive isolates were positive by PCR for a bla SHV gene. No isolates were identified as carrying bla TEM , although eight isolates had isoelectric points of 5-6.3, suggesting the presence of a possible TEM -lactamase. The results for the H. alveii isolates suggest that either an AmpC-like enzyme or a transferable -lactamase which is not TEM/SHV is present. This study shows that a wide range of genotypically and phenotypically different isolates of Enterobacteriaceae producing ESBL-like enzymes is present throughout the UK at a frequency of about 1% of unselected isolates. It is important that surveillance of resistance to these clinically important antibiotics is maintained as the occurrence of localized or more widespread outbreaks caused by bacteria producing ESBLs is to be expected.
Introduction
Resistance to -lactam antibiotics in Gram-negative bacteria can be due to three mechanisms: decreased permeability of the drug into the cell, hydrolysis of the drug by -lactamase or decreased affinity of the target penicillin-binding proteins (PBPs). 1 The major mechanism of resistance in bacteria causing clinically significant infection remains the expression of -lactamases, of which there are several classes including plasmid-encoded and chromosomally encoded enzymes. Overproduction of Richmond & Sykes Class I or Bush Group I 2 chromosomal -lactamase has led to resistance to many -lactams, including cefotaxime and ceftazidime, in many species of Enterobacteriaceae and Pseudomonas aeruginosa. 3 However, the impact of this mechanism of resistance on therapy can be limited by avoiding the use of certain cephalosporins, thereby reducing the chance of selecting highly resistant bacteria, and by good infection control procedures limiting the spread of the bacteria in the hospital environment. New plasmid-mediated -lactamases, extended-spectrum -lactamases (ESBLs), confer resistance to most -lactams except cephamycins and carbapenems. [4] [5] [6] As with other plasmid-mediated mechanisms of resistance, the genetic information encoding the -lactamase can be transferred between many Gramnegative and Gram-positive bacteria and, if antibiotic pressure is maintained, resistance can become ubiquitous within a particular environment. 7 There is evidence that at least some of the 'mutated' ESBLs retain the ability to move between replicons by transposition. 8 Overproduction of chromosomal -lactamase occurs predominantly in those species of Enterobacteriaceae which have an inducible system, namely Enterobacter cloacae, Serratia marcescens and Citrobacter freundii. Escherichia coli and Klebsiella species without an inducible system predominantly harbour plasmid-mediated ESBLs, although recently some Group 1 chromosomal -lactamases have become mobilized on plasmids.
The aims of this study were (i) to determine the prevalence in the UK of resistance to ceftazidime and/or cefotaxime in Enterobacteriaceae isolated from hospital in-patients (excluding urine specimens) and (ii) to examine all E. coli, Klebsiella spp. and Hafnia alveii and any isolates with unusual patterns of -lactam resistance to determine the mechanism of resistance.
Materials and methods

Bacterial isolates
One hundred non-duplicate Enterobacteriaceae isolated from 100 specimens (excluding urine) from 100 hospital in-patients were requested from hospitals in the UK. All isolates received were subcultured on to Maconkey agar and checked for purity. All pure Gram-negative, oxidasenegative isolates were initially tested for susceptibility (see below) to three -lactams (ceftazidime, cefotaxime and amoxycillin) with or without 20 mg/L clavulanic acid. Isolates resistant to 2 mg/L ceftazidime or cefotaxime were further examined for susceptibility to eight -lactams / 20 mg/L clavulanic acid and to several chemically unrelated antimicrobial agents. The identity of each isolate was determined by API20E and isolates were stored on agar slopes at 70°C in Protect tubes. Control strains were: (i) E. cloacae NCTC 10005 (A1), C. freundii NCTC 9750 (E8), S. marcescens NCTC 10211 (B15), Morganella morganii NCTC 235 (J29), Providencia stuartii NCTC 10318 (D8) and P. aeruginosa NCTC 10662 (G1) expressing inducible and constitutive Richmond & Sykes Class I chromosomal -lactamases, and Klebsiella pneumoniae expressing chromosomal -lactamase K1; and (ii) E. coli NCTC 10418, K. pneumoniae NCTC 9633, and E. coli and K. pneumoniae expressing plasmid-mediated -lactamases TEM-1, TEM-2, TEM-3, TEM-5, TEM-6, TEM-9, TEM-10, SHV-1 and SHV-2. 6 cfu, and aerobic incubation at 37°C overnight. The MIC of the antibiotic was defined as that concentration (in mg/L of agar) at which no more than two colonies were detected. For the higher inoculum a slight haze of growth was ignored. The determination of MIC was performed on at least three separate occasions during the study period (1990-93).
Media, antibiotics and susceptibility determination
Preparation of crude -lactamase, isoelectric focusing and -lactamase assays
All resistant isolates were grown to late logarithmic phase (optical density at 675 nm of 0.7-1.0) and a cell-free crude -lactamase extract prepared by differential centrifugation and sonication essentially as described in Piddock et al. 9 For all nitrocefin-positive extracts the isoelectric point (pI) of each -lactamase was determined on at least two separate occasions by focusing the crude extract on an LKB Multiphor on preformed polyacrylamide gels covering the pH range 3-10. The -lactamases on all gels were detected with nitrocefin, and the pI was calculated by reference to a calibration curve constructed from the relative mobility of the isoelectric focusing markers (Pharmacia-LKB, St Albans, UK).
For all resistant isolates the presence of an inducible Richmond & Sykes Class I -lactamase was examined by a disc approximation test between cefoxitin, cefotaxime and cefamandole. 3 The presence of a plasmid-mediated -lactamase was detected by disc susceptibility to mezlocillin, 10 and the presence of an ESBL was determined with a disc approximation test between co-amoxiclav, ceftazidime and cefotaxime. 4 For all E. coli, K. pneumoniae and H. alveii apparently expressing a plasmid-mediated ESBL the ability of the crude extracts to hydrolyse ceftazidime and cefotaxime was determined by a bioassay developed for this purpose.
A crude extract of -lactamase (1 mg protein) was placed into a well cut into an assay plate seeded with a 1 : 200 dilution of an overnight broth culture of the indicator organism (M. morganii J123). About 1 cm away from the well a 30 g disc of test antibiotic was placed such that for a well with no -lactamase the zone of inhibition encompassed the furthermost edge of the well. After 24 h incubation at 37°C the zone sizes were measured and compared with those from the control strains. A negative result was defined as one in which the zone of inhibition was unchanged compared with the buffer control. A positive result suggesting hydrolysis was indicated by blunting of the zone of inhibition. Slight blunting was designated / , increasing to marked reduction of the zone of inhibition (
). In addition, for all bioassay-positive extracts the hydrolysis of cephaloridine, ceftazidime and/or cefotaxime was determined. All assays were performed as described by Piddock et al. 11 and the relative rate of hydrolysis of ceftazidime and cefotaxime was compared with that of cephaloridine calculated.
Extraction and electrophoresis of plasmid DNA
All resistant E. coli, K. pneumoniae and H. alveii were examined for the presence of plasmid DNA by a modification of the alkaline-lysis method of Kado & Liu 12 and Jacoby & Medeiros 5 for improved isolation of large plasmids (I. McLaren, personal communication) on at least three separate occasions, and was essentially as follows: bacteria were harvested and washed by centrifugation from 1.5 mL of overnight broth. The cells were lysed by incubation in 2 M NaOH in SDS-Tris at 56°C for 35 min. The lysate was cooled at 4°C for 10 min, then cold phenol-chloroform was added and mixed gently for approximately 10 s. One hundred microlitres of the aqueous upper phase was removed to fresh tubes and used immediately or frozen at 20°C. If the plasmid DNA was required for transformation it was further treated to remove any residual phenol, by washing with diethyl ether, addition of sodium acetate, and precipitation and washing with ice-cold ethanol. The clean plasmid DNA was resuspended in sterile distilled water and visualized by agarose electrophoresis and ethidium bromide staining sizes being determined against standard plasmids from E. coli 39 R861 (98, 42, 24, 4.6 MDa) and E. coli V517 (32, 5, 3.5, 3, 2.2, 1.7, 1.5 MDa).
Transfer of resistance
All resistant isolates that possessed plasmid DNA were mated with E. coli HB101 and E. coli C600 on plates as described by Robillard. 13 In addition, the plasmid DNA was transformed into competent cells of both strains of E. coli. 14 The selection plates contained ceftazidime or cefotaxime 3 mg/L or ampicillin 100 mg/L in both the transformation and conjugation experiments, and in the latter nalidixic acid 25 mg/L was added to select the recipient strain. Control plasmids were RK2, TEM-1 and TEM-9, and as experimental controls all strains were subcultured alone to selection plates in parallel for every experiment to ensure that only transconjugants/transformants were selected and not spontaneous mutants. All transfer experiments were performed on at least three separate occasions.
Polymerase chain reaction (PCR) for TEM and SHV -lactamases
A colony of each test isolate was removed with a toothpick from an overnight culture on Isosensitest agar, and suspended in 50 L of sterile distilled water. The cells were lysed by heating to 95°C for 5 min. The 50 L PCR mixture contained: 2 L bacterial lysate, 30 pmol primers (see below), 0.2 mM Ultrapure dNTP (Pharmacia), 50 mM Tris-HCl pH 9.0 at 25°C, 50 mM sodium chloride, 2 mM (for TEM) or 0.6 mM (for SHV) magnesium chloride, 0.1% gelatin and 1 unit of SuperTaq DNA polymerase (HT , Cambridge, UK). The mixture was overlaid with sterile mineral oil and cycled in an Omnigene Thermal Cycler (Hybaid, Teddington, UK) 30 times as follows: 15 s denaturation at 94°C, 30 s annealing at 50°C, 1.5 min extension at 72°C; a final extension of 5 min at 72°C was added at the end of the 30 cycles. The oligonucleotide primer pairs 15 were used to detect TEM -lactamase genes and have been previously described; 15, 16 primer combination B and H gave an 869 bp amplimer while C and E produced a 347 bp amplimer. Oligonucleotides used to detect the SHV -lactamase genes were designed from the sequence data of BillotKlein et al. 17 and were: (forward) 5 -GCG AAA GCC AGC TGT CG and (reverse) 5 -ATT CGG GCC AAG CAG GGC GAC and gave an amplimer of 649 bp. These results were confirmed using the primer combination described by M'Zali et al.
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Results
Survey and analysis of all resistant clinical isolates
Forty-six hospitals agreed to save 100 non-duplicate consecutive isolates of Enterobacteriaceae from 100 patients. Of these hospitals four failed to send any isolates and five did not send 100. A total of 3951 isolates were received between 25th February 1990 and 28th February 1991; 206 of these were immediately discarded due to mixed cultures. The initial screen was designed to identify isolates likely to express an EBSL and this identified 409/3745 (10.92%) isolates apparently resistant to 2 mg/L ceftazidime and/or cefotaxime. From further testing 338/409 (9.02% of 3745) isolates were identified as Enterobacteriaceae, H. alveii or Acinetobacter spp. and were found to be resistant to 2 mg/L ceftazidime and/or cefotaxime ( Table I) . Each of the 42 hospitals in the study sent at least one resistant isolate. During the following 12 months 80 isolates were found to have reverted to susceptibility or did not survive storage.
There were 67 (1.8% of 3745 isolates) resistant strains of E. coli (n 29), Klebsiella spp. (n 31), Klebsiella oxytoca (n 4) and H. alveii (n 7) isolated by 27 hospitals (Table II) which were retained for further study to characterize the mechanism of resistance. Eighteen (26%) of 69 strains of E. coli, K. pneumoniae or H. alveii came from sputum with the remainder from various sites (10 wound, 12 miscellaneous swabs from body sites; seven abscesses from miscellaneous sites; the rest from stools, catheter tips, shunts, body fluids and blood cultures). The distribution of sites was similar to that of the main collection.
The pI of the crude -lactamase of all 338 resistant isolates was determined by isoelectric focusing, and the ability of various -lactams to exert synergy or antagonism examined by disc diffusion assay for each isolate. Only one E. coli, six K. pneumoniae, one E. cloacae, one Enterobacter agglomerans and one Serratia liquefaciens exhibited the pattern of synergy between cephalosporins and co-amoxiclav, suggesting the presence of an extendedspectrum plasmid-mediated -lactamase (Table III) . Another four of the E. coli were resistant to co-amoxiclav. The remaining Enterobacter spp., Citrobacter spp., M. morganii and most S. marcescens expressed a single -lactamase with an isoelectric point of 8.0. A few isolates contained two or more -lactamases with isoelectric points suggesting a TEM -l a c t a m a s e associated with a chromosomal Richmond & Sykes Class I -lactamase. The MICs of the eight antibiotics against these isolates showed that they were highly resistant to most -lactams and suggested that the expression of the enzyme was constitutive (derepressed). The mechanism of resistance in Proteus spp. was not examined in detail, but most of the MICs of the -lactams were unaffected by the addition of clavulanic acid and none of the -lactams exhibited synergy or antagonism. Several enzymes were expressed by the isolates as different pI were obtained (data not shown).
Mechanism of resistance in E. coli (n 29)
The susceptibility of 21 of the E. coli to ceftazidime was increased by the addition of clavulanic acid (Table III) . After prior incubation of many of the isolates in broth containing 25 mg/L ampicillin the agar dilution MICs of the cephalosporins were higher and, conversely, in the presence of clavulanic acid were lower than those for the same isolates grown in broth without ampicillin. The crude -lactamase of nine of these isolates hydrolysed ceftazidime when tested by bioassay, but not when examined using a spectrophotometer. The susceptibility of the remaining 11 isolates to ceftazidime was unaffected by addition of clavulanic acid, and of these the crude -lactamases from two were positive in the bioassay, but not when measured spectrophotometrically. The s u s c e p t i b i l i t y of 18 of the E. coli to cefotaxime was increased by the addition of clavulanic acid (Table III) . The crude -lactamase of 12 of these isolates hydrolysed cefotaxime when tested by bioassay, but not by spectrophotometer. The susceptibility of the remaining six isolates to cefotaxime was unaffected by clavulanic acid, and the crude -lactamase from all was positive in the bioassay, but not spectrophotometrically.
The pI of the crude -lactamase preparations showed that for 12 of the isolates only one enzyme was detected, eight isolates expressed two enzymes and two three enzymes. The high pI of 8-9 suggests expression of an ampC chromosomal -lactamase by 11 of the isolates, whereas the pI of 5-6.5 suggests expression of a TEM -lactamase by 17 of the isolates (confirmed in most strains by a positive PCR result), and a pI of 7-7.5 expression of a SHV -lactamase by five of the isolates, although no SHV genes were detected by PCR. No detectable -lactamase (by nitrocefin reaction) could be detected from isolate 31/058.
Twenty of 29 E. coli examined contained one or more plasmids, but only two of the isolates (10/011 and 18/060) transferred the resistance to E. coli HB101 by selection with 3 mg/L ceftazidime. Resistance was not transferred by transformation with the plasmid DNA extracted from any of the isolates. During the transfer experiments, putative transconjugants (colonies from the mating) from most isolates grew on selective media but neither the donors (isolates) nor the recipients grew. Subculture to non-selective media and susceptibility testing of ten clones from each mating uniformly showed that the colonies took several days to grow, unlike the donors or recipients, and that most were susceptible to ceftazidime and cefotaxime. Control conjugation and transformation experiments with strains expressing extended-spectrum TEM enzymes showed that these plasmids were successfully transferred and expressed in E. coli HB101 and C600 (data not shown). However, it was found that the yield of transformants from these control strains was improved by using 100 mg/L ampicillin rather than either of the cephalosporins.
Mechanism of resistance in Klebsiella spp. (n 29)
The susceptibility of 24 of the K. pneumoniae (n 2 7 ) to ceftazidime was reduced by the addition of clavulanic acid (Table IV) . As with the E. coli, prior incubation of many of the isolates in broth containing 25 mg/L ampicillin gave higher MICs of the cephalosporins and, in the presence of clavulanic acid, lower MICs than those for the same isolates grown in broth without ampicillin. The crude -lactamase of ten of these isolates was positive when tested by bioassay; seven hydrolysed ceftazidime slowly when examined using a spectrophotometer (data not shown). The susceptibility of the remaining five isolates to ceftazidime was unaffected by clavulanic acid, and none were positive in the bioassay. The -lactamase expressed by 16 of the isolates had a pI of 7-7.5, suggesting an SHV -lactamase, and not a K1 -lactamase, whereas for eight isolates the pI of 5-6.3 suggests expression of a TEM -lactamase. Twenty of the K. pneumoniae contained one or more plasmids, but only one isolate, 31/049, transferred the resistance to E. coli HB101 by selection with 3 mg/L ceftazidime or cefotaxime. As with the E. coli, putative transconjugants grew on the selective media whereas neither the donors (isolates) nor the recipients grew. Subculture to non-selective media and susceptibility testing of clones from each mating also showed that the colonies took several days to grow, unlike the donors or recipients, and that most were susceptible to ceftazidime and cefotaxime. Resistance was transferred from the plasmid DNA extracted from three isolates (31/049, 16/022, 9/038) by transformation and selection on ampicillin. None of the Klebsiella spp. yielded an amplimer by PCR for TEM, and 19 yielded an amplimer by PCR for SHV. The MICs of ceftazidime and cefotaxime were reduced by clavulanic acid for all four isolates of K. oxytoca, crude -lactamase extracts from all isolates hydrolysed cefotaxime, but only one hydrolysed ceftazidime. One isolate (31/049) transferred ceftazidime resistance by both conjugation and transformation.
Mechanism of resistance in H. alveii (n 7)
The susceptibility of only three of the H. alveii to ceftazidime was reduced by the addition of clavulanic acid (Table V) , and the crude -lactamase from two was positive when tested by bioassay. The susceptibility of the remaining four isolates to ceftazidime was unaffected by clavulanic acid and, of these, the crude -lactamase from two was positive in the bioassay.
The pI of the crude -lactamase preparations showed that for four of the isolates only one enzyme was detected and three isolates expressed two enzymes. By analogy with the Enterobacteriaceae the pI of 8.3-8.9 suggests a chromosomal -lactamase in five isolates, whereas the pI of 5.4-5.5 suggests a TEM -lactamase. The enzyme with a pI of 7.9 may be chromosomal in view of the negative PCR results with SHV primers. Four of the isolates examined contained plasmid DNA, two of which transformed the resistance to E. coli HB101 by selection with ampicillin. The PCR did not yield any amplimers for TEM or SHV genes.
Discussion
Recently, it has become increasingly clear that manylactamases are capable of conferring resistance to extended-spectrum cephalosporins. Initially, group 2b enzymes, such as TEM-3, TEM-5, TEM-7 and TEM-10, and SHV-2 and SHV-3, were recognized as plasmidencoded enzymes distinct from the group 1 chromosomal enzymes which, when activated, confer resistance to extended-spectrum cephalosporins. However, the description and characterization of Ambler class A plasmid -lactamases, such as CTX-M-1, has blurred this division. 19 CTX-M-1 is homologous with MEN-1, has ESBL activity and is most closely related to the chromosomal -lactamase found in K. oxytoca. Similarly, plasmid -lactamases such as CMY-2 or BIL-1 reported from K. pneumoniae are most closely related to the -l a c t a m a s e encoded by ampC in C. freundii, a group 1 enzyme and Ambler class C. 20 The LEN-1 enzyme of K. pneumoniae is chromosomal and yet is most closely related to the SHV-1 family of enzymes, a plasmidic group 2b , probably because of the recent integration of the gene into the chromosome. Therefore, it was expected that in a national survey of a large number of isolates resistant to extended-spectrum cephalosporins, a large number of -lactamases would be encountered. Identification of the -lactamases was initially hampered by the lack of DNA sequence information and apparently conflicting biochemical evidence. Subsequently, it has been shown that many of the TEM and SHV enzymes can be reliably identified only by DNA sequencing or oligonucleotide probing of critical parts of the -lactamase gene open reading frame. Therefore TEM and SHV gene sequences were identified with PCR primers to highly conserved parts of these genes. Some discrepancies between pI data and PCR were noted (e.g. E. coli 18/095, 31/024 and 43/006) and this could be ascertained to loss of plasmids.
The determination of the pI has been a traditional mainstay of the study of -lactamases, but in this study pI gave no indication of enzyme type and enzymes that were apparently different as judged by pI came from isolates with identical MIC values. Recently, DNA probing of the OXY-1 and OXY-2 chromosomal enzymes from K. oxytoca, demonstrated the presence of multiple forms of two genes (probably non-functional amino acid substitutions) which results in a great diversity of pIs-eight different values from 5.2 to 8.8. 21 This makes the interpretation of pI data difficult, and some -lactamases can probably only be identified by very detailed molecular studies involving gene sequencing. A further complication in the identification of -lactamases arises from the variable significance of inhibition of -lactamases by clavulanic acid, as mutations in both SHV and TEM enzymes Arg244 in E. coli and K. pneumoniae lead to resistance to inhibition to clavulanic acid. 22 Site-directed mutagenesis of naturally occurring weak and strong promoters for different SHV ESBLs has demonstrated that the substrate profile can be markedly altered. 23 
Escherichia coli
The transfer experiments suggested that the mechanism of resistance in the resistant E. coli was unlikely to be mediated by a transferable ESBL, but was due to overexpression of a TEM or ampC -lactamase. Over-expression of TEM has been shown to increase the MICs of some -lactams. 24 Although the PCR results did not always suggest that a TEM enzyme was present, it is possible that a clavulanate-susceptible AmpC-type enzyme such as FEC-1 was present in some isolates. 25 Interestingly, there were nine such isolates in our survey suggesting that these previously rarely observed enzymes may be more common in clinical strains than expected from data collected in centres with a particular interest in -lactamases. For strain 2/011 (I311) the pI suggested an SHV enzyme but the PCR was positive for TEM not SHV. It may also be that from some isolates, clavulanic acid and ceftazidime are synergic by virtue of interaction with PBP 2 and PBP 3, respectively.
Klebsiella species
The transfer experiments and the hydrolysis data suggested that the mechanism of resistance in the K. pneumoniae was due to a transferable SHV -lactamase (e.g. 16/022, 9/038), or a non-transferable SHV type -lactamase or TEM -lactamase (31/049) (e.g. Table V ). The data for Klebsiella spp. were probably biased by isolates from hospital 16, which provided multiple isolates of K. pneumoniae with pI values consistent with an SHV-2 enzyme being present. The plasmid profiles varied widely, suggesting transfer of an indigenous plasmid carrying SHV-2 genes together with transposition of the SHV-2 gene on to chromosome/plasmids. 16 Isolate 16/088 had a pI consistent with an SHV-4 enzyme.
Five isolates of K. pneumoniae showed inhibition by clavulanic acid of -lactamase(s) active against ceftazidime and cefotaxime, but were negative with PCR primers for TEM and SHV genes. These enzymes appear to belong to the Bush group 2e but only the plasmidmediated FUR enzyme has been described hitherto in K. pneumoniae. These are, presumably, novel -l a c t a m a s e s which could become more widespread in the UK. K. oxytoca strain 14/021 may be a hyper-producer of K1 judging by its relative sensitivity to ceftazidime and poor protection by clavulanate.
Hafnia alveii
The transfer experiments and the hydrolysis data suggested that the mechanism of resistance in H. alveii was due to a chromosomal -lactamase or a transferable -lactamase which is not a TEM or SHV enzyme.
The study suggests that one isolate of E. coli or K. pneumoniae can harbour two variants of the same enzyme as defined by p I (e.g. 31/049) and the same TEM variant (as judged by pI) can be expressed by two different species from the same specimen. As noted by other workers 16 it has been exceptionally difficult to transfer the gene encoding cephalosporin-resistance to a new host. In one study of TEM-10, TEM-12 and TEM-26, only 31% of isolates of Enterobacteriaceae transferred these genes by conjugation. 16 Clearly, these genes move on to replicons which are incapable of easy conjugal transfer but can continue to move rapidly amongst bacterial species and strains leading to exceedingly complicated epidemiological situations. It is disturbing that the widely used double disc diffusion screening test performed poorly in our study compared with hydrolysis of ESBLs using a spectrophometric method. There is clearly a need for improved phenotypic screening tests for detecting ESBLs in the clinical laboratory.
